논문KCI 등재
Assessment of Medication Adherence and Pharmacist Intervention Are Important for the Care of Patients with Inflammatory Bowel Disease
1
조회
0
다운로드
1
인용
0
참고문헌
참고문헌 (10)
- Michetti P, "Impact of treatment-related beliefs on medication adherence in immunemediated inflammatory diseases : results of the Global ALIGN Study", Adv Ther, 34, pp.91~108 (2017)
- Kane SV, "Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis", Am J Gastroenterol, 96, pp.2929~2933 (2001)
- Kane SV, "Review article : understanding adherence to medication in ulcerative colitis : innovative thinking and evolving concepts", Aliment Pharmacol Ther, 32, pp.1051~1058 (2010)
- Kane S, "Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis", Am J Med, 114, pp.39~43 (2003)
- Kane SV, "Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn’s disease patients", Adv Ther, 26, pp.936~946 (2009)
- Mitra D, "Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis", BMC Gastroenterol, 12, pp.132~ (2012)
- Osterberg L, "Adherence to medication", N Engl J Med, 353, pp.487~497 (2005)
- Kim Jae Song, "Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis", Gut and Liver, 16(5), pp.736~745 (2022), 거트앤리버 소화기연관학회협의회[DOI]
- Anghel LA, "An overview of the common methods used to measure treatment adherence", Med Pharm Rep, 92, pp.117~122 (2019)
- Turner D, "STRIDE-II : an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease(STRIDE)Initiative of the International Organization for the Study of IBD(IOIBD) : determining therapeutic goals for treat-to-target strategies in IBD", Gastroenterology, 160, pp.1570~1583 (2021)
관련 논문AI추천
Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis권경희, 유윤미, 천재희, Geum Min Jung, Kim Jae Song, Son Eun Sun거트앤리버 소화기연관학회협의회 · Gut and Liver2022 · 제16권 제5호Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease조영석, 최현호거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제3호Optimizing Infliximab Use in Real-World Inflammatory Bowel Disease: Insights from a Population Pharmacokinetic Model Integrating Intravenous and Subcutaneous FormulationsJung Sung Hoon, Kang Sang-Bum거트앤리버 소화기연관학회협의회 · Gut and Liver2025 · 제19권 제3호Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?천재희, Park Jihye거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제5호Clinical usefulness of remote patient monitoring using e-Health technologies in patients with inflammatory bowel diseasesSung Noh Hong대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제5호Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis천재희, Jae Hyun Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제2호
이 간행물의 다른 논문 (17건)
What Is the Optimal Surrogate Indicator for a Miss Rate of Adenoma in Colonoscopy?Hong Seung Wook, Byeon Jeong-Sikpp. 661-662Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?Park Suhyun, Park Sang Hyoungpp. 663-664Gastric Outlet Obstruction: Current Status and Future DirectionsSiersema Peter D., Papanikolaou Ioannis S.pp. 667-675What Are the Different Phenotypes of Inflammatory Bowel Disease in Asia?Park Su Bee, 윤진영, 차재명pp. 676-685The Role of Gut Microbiota and Genetic Susceptibility in the Pathogenesis of PancreatitisLiu Kaijun, Chen Xiao, Wang Ming, Xu Fumin, Yang Chunmei, Tang Mingcheng, Cheng Zhenhao, Chen Dongfengpp. 686-696
